The effect of interstitial pressure on tumor growth: Coupling with the blood and lymphatic vascular systems

被引:171
作者
Wu, Min [1 ]
Frieboes, Hermann B. [2 ,3 ]
McDougall, Steven R. [4 ]
Chaplain, Mark A. J. [5 ]
Cristini, Vittorio [6 ,7 ]
Lowengrub, John [1 ,8 ]
机构
[1] Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA
[2] Univ Louisville, Dept Bioengn, Louisville, KY 40292 USA
[3] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA
[4] Heriot Watt Univ, Inst Petr Engn, Edinburgh, Midlothian, Scotland
[5] Univ Dundee, Div Math, Dundee, Scotland
[6] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA
[7] Univ New Mexico, Dept Chem Engn, Albuquerque, NM 87131 USA
[8] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA
关键词
Vascular growth; Angiogenesis; Microenvironmental transport barriers; Interstitial fluid flow; NONLINEAR SIMULATION; INDUCED ANGIOGENESIS; MATHEMATICAL-MODELS; VESSEL COOPTION; FLUID PRESSURE; SOLID TUMORS; CELL; CANCER; FLOW; NOTCH;
D O I
10.1016/j.jtbi.2012.11.031
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The flow of interstitial fluid and the associated interstitial fluid pressure (IFP) in solid tumors and surrounding host tissues have been identified as critical elements in cancer growth and vascularization. Both experimental and theoretical studies have shown that tumors may present elevated IFP, which can be a formidable physical barrier for delivery of cell nutrients and small molecules into the tumor. Elevated IFP may also exacerbate gradients of biochemical signals such as angiogenic factors released by tumors into the surrounding tissues. These studies have helped to understand both biochemical signaling and treatment prognosis. Building upon previous work, here we develop a vascular tumor growth model by coupling a continuous growth model with a discrete angiogenesis model. We include fluid/oxygen extravasation as well as a continuous lymphatic field, and study the micro-environmental fluid dynamics and their effect on tumor growth by accounting for blood flow, transcapillary fluid flux, interstitial fluid flow, and lymphatic drainage. We thus elucidate further the non-trivial relationship between the key elements contributing to the effects of interstitial pressure in solid tumors. In particular, we study the effect of IFP on oxygen extravasation and show that small blood/lymphatic vessel resistance and collapse may contribute to lower transcapillary fluid/oxygen flux, thus decreasing the rate of tumor growth. We also investigate the effect of tumor vascular pathologies, including elevated vascular and interstitial hydraulic conductivities inside the tumor as well as diminished osmotic pressure differences, on the fluid flow across the tumor capillary bed, the lymphatic drainage, and the IFP. Our results reveal that elevated interstitial hydraulic conductivity together with poor lymphatic function is the root cause of the development of plateau profiles of the IFP in the tumor, which have been observed in experiments, and contributes to a more uniform distribution of oxygen, solid tumor pressure and a broad-based collapse of the tumor lymphatics. We also find that the rate that IFF is fluxed into the lymphatics and host tissue is largely controlled by an elevated vascular hydraulic conductivity in the tumor. We discuss the implications of these results on microenvironmental transport barriers, and the tumor invasive and metastatic potential. Our results suggest the possibility of developing strategies of targeting tumor cells based on the cues in the interstitial fluid. (c) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:131 / 151
页数:21
相关论文
共 50 条
  • [41] Effect of thalidomide and arsenic trioxide on the release of tumor necrosis factor-α and vascular endothelial growth factor from the KG-1a human acute myelogenous leukemia cell line
    Girgis, Erian H.
    Mahoney, John P.
    Khalil, Rafaat H.
    Soliman, Magdi R.
    ONCOLOGY LETTERS, 2010, 1 (04) : 663 - 667
  • [42] Effect of Different Concentrations of Leukemia Inhibitory Factor on Gene Expression of Vascular Endothelial Growth Factor-A in Trophoblast Tumor Cell Line
    Jahanbin, Khodakaram
    Ghafourian, Mehri
    Rashno, Mohammad
    INTERNATIONAL JOURNAL OF FERTILITY & STERILITY, 2020, 14 (02) : 116 - 121
  • [43] A Delayed Dynamical Model Describing the Effect of Tumor-Induced Vascular Endothelial Growth Factor on Angiogenesis: Backward Bifurcations and Global Dynamics
    Chen, Jiawen
    Ma, Wanbiao
    Feng, Zhaosheng
    INTERNATIONAL JOURNAL OF BIFURCATION AND CHAOS, 2022, 32 (08):
  • [44] EORTC Receptor and Biomarker Study Group report: A sandwich enzyme-linked immunosorbent assay for vascular endothelial growth factor in blood and tumor tissue extracts
    Span, PN
    Grebenchtchikov, N
    Geurts-Moespot, J
    Westphal, JR
    Lucassen, AMJ
    Sweep, CGJ
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2000, 15 (02) : 184 - 191
  • [45] Evaluation of a novel blood pressure scoring method and its association with clinical response in cancer patients treated with anti-vascular endothelial growth factor therapy
    Bilen, Mehmet Asim
    Durand, Jean-Bernard
    McQuinn, Lacey
    Hess, Kenneth R.
    Fu, Siqing
    Falchook, Gerald S.
    Hong, David S.
    Wheler, Jennifer J.
    Said, Rabih
    Ewer, Michael S.
    Kurzrock, Razelle
    Naing, Aung
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (04) : 717 - 722
  • [46] Effect of the Multitargeted Receptor Tyrosine Kinase Inhibitor, ABT-869 [N-(4-(3-Amino-1H-indazol-4-yl)phenyl)-N′-(2-fluoro-5-methylphenyl)urea], on Blood Pressure in Conscious Rats and Mice: Reversal with Antihypertensive Agents and Effect on Tumor Growth Inhibition
    Franklin, Pamela H.
    Banfor, Patricia N.
    Tapang, Paul
    Segreti, Jason A.
    Widomski, Deborah L.
    Larson, Kelly J.
    Noonan, William T.
    Gintant, Gary A.
    Davidsen, Steven K.
    Albert, Daniel H.
    Fryer, Ryan M.
    Cox, Bryan F.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 329 (03) : 928 - 937
  • [47] Pancreatic head carcinoma and vascular endothelial growth factor (VEGF-A) concentration in portal blood: its association with cancer grade, tumor size and probably poor prognosis
    Hogendorf, Piotr
    Durczynski, Adam
    Kumor, Anna
    Strzelczyk, Janusz
    ARCHIVES OF MEDICAL SCIENCE, 2014, 10 (02) : 288 - 293
  • [48] Vascular endothelial growth factor-D transgenic mice show enhanced blood capillary density, improved postischemic muscle regeneration, and increased susceptibility to tumor formation
    Karkkainen, Anna-Mari
    Kotimaa, Antti
    Huusko, Jenni
    Kholova, Ivana
    Heinonen, Suvi Elina
    Stefanska, Anna
    Dijkstra, Marike Hinke
    Purhonen, Hanna
    Hamalainen, Eveliina
    Makinen, Petri Ilmari
    Turunen, Mikko Petri
    Yla-Herttuala, Seppo
    BLOOD, 2009, 113 (18) : 4468 - 4475
  • [49] Inhibition of vascular endothelial growth factor in young adult mice causes low bone blood flow and bone strength with no effect on bone mass in trabecular regions
    Lane, N. E.
    Nyman, J. S.
    Uppuganti, S.
    Chaudhari, A. J.
    Aguirre, J., I
    Shidara, K.
    Liu, X. P.
    Yao, W.
    Kimmel, D. B.
    BONE REPORTS, 2019, 10
  • [50] Effect of Non-Surgical Periodontal Treatment on Gingival Crevicular Fluid and Serum Endocan, Vascular Endothelial Growth Factor-A, and Tumor Necrosis Factor-Alpha Levels
    Turer, Cigdem C.
    Durmus, Duygu
    Balli, Umut
    Guven, Berrak
    JOURNAL OF PERIODONTOLOGY, 2017, 88 (05) : 493 - 501